Publicaciones en colaboración con investigadores/as de Beth Israel Deaconess Medical Center (1)

2017

  1. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

    The Lancet, Vol. 389, Núm. 10081, pp. 1799-1808